Avinew oculonas. susp./susp. for drinking water (lyoph.) vial

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Newcastle Disease Virus (live, attenuated)

MAH:

Boehringer Ingelheim Animal Health Belgium SA-NV

ATC_code:

QI01AD06

INN:

Avian Pseudopest Virus (Newcastle Disease) (ND), Attenuated

pharmaceutical_form:

Lyophilisate for oculonasal suspension/use in drinking water

composition:

Avian Pseudopest Virus (Newcastle Disease) (ND), Attenuated

administration_route:

Ocular use; Oculonasal use; Oral use

therapeutic_group:

poultry

therapeutic_area:

Newcastle Disease Virus / Paramyxovirus

leaflet_short:

CTI code: 235514-04 - Pack size: 10 x 2000 doses - Commercialisation status: YES - CNK code: 2104057 - Delivery mode: Medical prescription; CTI code: 235514-03 - Pack size: 10 x 1000 doses - Commercialisation status: NO - CNK code: 1774272 - Delivery mode: Medical prescription; CTI code: 235514-02 - Pack size: 2000 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 235514-01 - Pack size: 1000 doses - Commercialisation status: NO - Delivery mode: Medical prescription

authorization_status:

Commercialised: Yes

authorization_date:

2002-04-15